Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

4.14
Delayed Data
As of Apr 24
 +0.02 / +0.49%
Today’s Change
2.81
Today|||52-Week Range
8.47
-13.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization153.0K157.0K97.0K106.0K
 
 
 
 
 
 
Operating ExpensesGross Income-153.0K-157.0K-97.0K-106.0K
 
 
 
 
 
General Expenses3.7M3.4M4.9M7.3M
 
 
 
 
 
Research And Development1.7M1.8M2.9M4.8M
 
 
 
 
 
Total Operating Expenses3.9M3.5M5.0M7.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.9M-3.5M-5.0M-7.4M
 
 
 
 
 
Interest Expense On Debt192.0K0.00--0.00
 
 
Other Expenses132.0K0.000.00-1.8M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.9M-3.4M-4.9M-9.2M
 
 
 
 
 
Income Taxes-5.0K-5.0K-25.0K0.00
 
 
 
 
Net Income-3.9M-3.4M-4.9M-9.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.0M9.2M10.7M13.7M
 
 
 
 
 
Shares To Calculate EPS Diluted8.0M9.2M10.7M13.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.45-$0.30-$0.45-$0.68
 
 
 
 
 
EPS Diluted-$0.45-$0.30-$0.45-$0.68
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account